Codiak Biosciences Files for Chapter 11 Bankruptcy Protection.
TL;DR Summary
Codiak BioSciences has filed for Chapter 11 bankruptcy and most executives, including founder Doug Williams, are leaving the company. Codiak is currently in talks with potential buyers and expects to sell the entire company or core assets soon. The biotech was founded in 2015 with the goal of turning exosomes into medicines. The bankruptcy news caused the stock to drop by 30%.
- Codiak files for Chapter 11 bankruptcy as most executives head for the exit Endpoints News
- Codiak BioSciences to Pursue Asset Sale through Voluntary Chapter 11 Process GlobeNewswire
- Cash-strapped biotech firm Codiak files for bankruptcy protection Reuters
- Codiak Biosciences files for bankruptcy FierceBiotech
- View Full Coverage on Google News
Reading Insights
Total Reads
0
Unique Readers
3
Time Saved
8 min
vs 9 min read
Condensed
96%
1,684 → 62 words
Want the full story? Read the original article
Read on Endpoints News